In Israeli medicine, oncohematology is one of the priority areas of oncology. In recent years, innovative methods for treating malignant blood pathologies have been developed and implemented in clinical practice, achieving sustained remission and complete recovery in 90-95% of patients with rare diseases such as hemasarkoma. Treatment of hemasarkoma in Israel follows a comprehensive program that includes the most effective therapeutic methods for the patient. Through progressive methods such as CAR-T therapy, targeted therapy, the use of the latest chemotherapeutics, and bone marrow transplantation, oncohematologists are able to improve prognosis and achieve positive results in patients deemed hopeless in their home countries.
Positive dynamics are observed when effective therapy is conducted at the initial stage of the disease. Unfortunately, timely diagnosis is complicated by the fact that at the first stage, symptoms usually do not manifest, and the patient does not seek medical help. In the diagnostic departments of Israeli clinics, examinations are conducted using modern equipment that allows for accurate identification of pathology even in cases where characteristic clinical signs are not pronounced. The molecular genetic testing used provides the necessary data for selecting drugs that act destructively on these malignant cells. An undeniable advantage of treatment in Israel is the use of not only effective but also gentle drugs for the patient's body. Patient reviews also confirm that the cost of therapy is significantly lower than in Europe and the USA, making it quite accessible for medical tourists.
Treatment Methods for the Disease
Hemasarkomas develop outside the bone marrow and affect lymph nodes, the spleen, skin, and several other organs. Malignantly altered cells in bone marrow tissues are detected in cases of pronounced disease progression. Despite years of research, the exact causes of this oncological disease remain unclear. Specialists agree that hereditary factors, ionizing radiation, and a decrease in immune activity due to various reasons contribute to mutations in blood cells.
The treatment program aims to eliminate symptoms, prevent disease progression, normalize the patient's condition, and achieve prolonged stable remission. Treatment is conducted using both traditional and progressive methods.
Chemotherapy
Among traditional methods of anti-tumor therapy, chemotherapy is the most effective and serves as the primary treatment for hemasarkoma. Considering that cytostatic drugs, upon entering the bloodstream, are distributed throughout the patient's body, they exert a systemic effect. To achieve the desired positive result, polychemotherapy is prescribed — the simultaneous administration of several chemotherapeutics. The destructive effect of these drugs on cancer cells is due to damage to nuclear structures, making growth and chaotic division impossible, and stimulating programmed cell death — apoptosis.
In the treatment of oncological diseases in Israeli clinics, highly effective low-toxicity types of next-generation cytostatics are used, which gently affect the weakened body of the patient without causing pronounced side effects. As a result of the chemotherapy course, clinical signs significantly weaken, the patient's well-being improves, and the pathology subsides. The administration of high doses of chemotherapeutics requires supportive therapy to minimize possible damage. For this purpose, medications to normalize kidney and heart function, as well as hepatoprotectors, are indicated.
Targeted Therapy
One of the most effective modern methods of anti-tumor therapy involves the use of drugs that exert targeted negative effects on pathologically altered cells without affecting healthy ones. For the treatment of hemasarkoma, drugs containing monoclonal antibodies that specifically recognize surface receptor proteins of malignant cells are used. Targeted drugs that include a radioactive isotope delivered to the cancer cell have also proven to be very effective. Due to the lack of impact on healthy cells, the course of targeted therapy does not cause side effects in the patient. Israeli clinics offer the latest types of targeted drugs produced at the country's pharmaceutical factories.
CAR-T Therapy
CAR-T therapy represents one of the newest methods of immunotherapy, which involves artificially endowing the patient's T-lymphocytes with the ability to quickly recognize and destroy tumor cells. This highly effective innovative method involves creating a drug from lymphocytic cells obtained from the patient's blood. Through gene-engineering modifications, T-lymphocytes begin to synthesize the CAR receptor on their surface membrane, which includes the receptor protein of the T-lymphocyte and an antibody to the cells of this tumor. Once in the patient's body, the CAR receptor quickly recognizes malignant cells and stimulates their destruction.
During the time required to obtain the CAR drug, the patient is indicated for aggressive chemotherapy to suppress immunity, which is necessary for the normal development and reproduction of modified lymphocytes. Due to the memory of immune cells about previously encountered foreign agents, the therapeutic effect is noted long after the course is completed.
Bone Marrow Transplantation
Bone marrow transplantation is necessary to restore hematopoietic function, which has been impaired due to the progression of the malignant process and the administration of high doses of chemotherapeutics to the patient. Autologous transplantation (transplantation of the patient's own bone marrow, harvested before chemotherapy) or allogeneic transplantation (transplantation of donor material) is performed. The procedure itself resembles a standard blood transfusion, after which the patient is placed in a sterile box for the time required to restore immunity. Staying in this room prevents infection by pathogenic agents.
Send your records — an Ichilov physician will reply within 1–2 days, free of charge.
Modern Methods of Disease Diagnosis
In Israeli clinics, a comprehensive examination is conducted in about three days.
Upon arriving at the clinic, the patient goes to see the treating oncohematologist. During the consultation, the doctor reviews the medical history and results of previous studies conducted in the patient's home country, asks the patient about their complaints, and compiles a medical history. After conducting a physical examination, the specialist prescribes the necessary additional examinations.
On this day, the patient undergoes the following examinations:
- complete blood count and biochemical blood tests;
- determination of the presence and level of certain tumor markers in the blood;
- sternal puncture;
- lumbar puncture;
- bone marrow biopsy and regional lymph node biopsy with histological examination of the obtained tissues;
- visual imaging methods (CT, MRI, PET-CT).
A medical commission, which includes the treating oncohematologist and specialized experts, reviews the obtained research results, makes an accurate diagnosis, and develops a treatment program.
How Much Does Treatment Cost
The price may vary depending on the specifics of the oncological disease, the patient's condition, and the duration of hospitalization. In any case, treatment in Israeli clinics costs foreign patients, on average, 30-50% less than in Western Europe and the USA.
Advantages of Treatment in Israel
- High qualification of oncohematologists, many of whom are recognized worldwide.
- Latest equipment.
- Application of progressive treatment methods.
- Use of innovative drugs.
- Affordable prices.
Considering the modern achievements in anti-tumor therapy, oncohematological diseases are no longer a death sentence. For successful recovery, one must not delay; it is essential to choose a clinic and undergo treatment as soon as possible.